Many Cancer Centers Experiencing Shortage of Carboplatin, Cisplatin
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, June 8, 2023 -- Ninety-three and 70 percent of cancer centers are currently experiencing a shortage of carboplatin and cisplatin, respectively, according to a report published June 7 by the National Comprehensive Cancer Network (NCCN).
Researchers surveyed medical centers to examine carboplatin and cisplatin shortages, including answers from 27 NCCN Member Institutions across the United States.
According to the survey, carboplatin supply has reached a critical stage in the last four weeks. Ninety-three percent of 27 centers reported a shortage of carboplatin. Of 25 centers, 64 percent reported that all patients currently receiving a carboplatin-containing regimen are being treated according to the intended dose and schedule, but mitigation strategies have been developed to allow for switches to equivalent regimens when possible. Only 40 percent of 25 centers reported having received any indication from manufacturers/suppliers as to when carboplatin will be readily available. Overall, 70 percent of 27 centers reported experiencing a shortage of cisplatin, which has been going on for many months although at a less critical level than carboplatin; all patients currently receiving cisplatin-containing regimens are being treated according to the intended dose and schedule. Only 39 percent of 18 centers reported receiving an indication of when cisplatin will be available.
"This is an unacceptable situation," Robert W. Carlson, M.D., the chief executive officer at NCCN, said in a statement. "We are hearing from oncologists and pharmacists across the country who have to scramble to find appropriate alternatives for treating their patients with cancer right now."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Recommendations Issued for Palliative RT for Symptomatic Bone Mets
THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...
Living Outside of Comprehensive Cancer Center Catchment Area Tied to Later-Stage Diagnosis
TUESDAY, May 28, 2024 -- Disadvantaged populations and those living outside of a comprehensive cancer center's main catchment area have higher odds of receiving a diagnosis of...
Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals
TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.